Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

Sleep's role to down-scale glutamate, excitatory, frontal cortical synapses is extended to include an up-scaling of metaplastic LTP potential, in recovery from prolonged waking induced saturation of ...

Using advanced psychiatric treatments like Deep Transcranial Magnetic Stimulation (TMS) and Spravato (Esketamine), we are able to help those patients that antidepressant medications have failed.

Living Local 15 host Jessica Williams is joined by Sean Goddard, a Psychiatric Nurse Practitioner and Owner of Viking Psychiatry, to speak about the recent approval for Spravato as a monotherapy ...

Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

My focus is on medication management, transcranial magnetic stimulation (TMS), and Spravato (esketamine). I know that starting a new medication or treatment can feel overwhelming or nerve-racking ...

When shopping for glutamine supplements, read labels carefully. Do not confuse glutamine for another chemical called glutamate (glutamic acid). Taking too much glutamate can cause seizures and kill ...